Sue Washer | Chief Executive Officer |
Bill Sullivan | Chief Financial Officer |
Matt Feinsod | Chief Medical Officer |
Yanan Zhu | Wells Fargo |
Pete Stavropoulos | H.C. Wainwright |
David Nierengarten | Wedbush Securities |
Matthew Luchini | BMO Capital Markets |
Good afternoon, and welcome to the AGTC Financial Results Conference Call for the Third Quarter of Fiscal Year 2018. Today's call is being recorded.
Before we get started, I would like to remind everyone that during the conference call, AGTC may make forward-looking statements, including statements about the company's financial results, its future business strategies and operations, and its product development and regulatory progress. Actual results could differ materially from those discussed in the forward-looking statements due to a number of important factors, including uncertainty inherent in the clinical development and regulatory process and other risks described in the Risk Factor section of AGTC's annual report on Form 10-K for the fiscal year-ended June 30, 2017.
For introductions and opening remarks, I like to turn the call over to Sue Washer, Chief Executive Officer of AGTC.